Successful treatment with glecaprevir/pibrentasvir for chronic hepatitis C complicated by primary biliary cholangitis.
Satoshi TakakusagiHitoshi TakagiYozo YokoyamaKyoko MarubashiKazuko KizawaTakashi KosoneKen SatoSatoru KakizakiToshio UraokaPublished in: Clinical journal of gastroenterology (2020)
GLE/PIB is an effective and tolerated choice for the treatment in cases of CHC complicated by PBC.